Wegovy produces significantly more weight loss than Ozempic, and the reason is straightforward: Wegovy delivers a much higher dose of the same drug. Both medications contain semaglutide, but Wegovy’s maintenance dose can reach up to 7.2 mg per week, while Ozempic tops out at 2 mg. That dose difference translates directly into more pounds lost.
Same Drug, Different Doses
Ozempic and Wegovy are both once-weekly semaglutide injections made by the same manufacturer, Novo Nordisk. They work identically in the body, slowing digestion, reducing appetite, and mimicking a gut hormone that signals fullness to your brain. The critical difference is what they’re approved for and how high the dose goes.
Ozempic is FDA-approved for type 2 diabetes management and reducing cardiovascular risk. Its maximum dose is 2 mg per week. Wegovy is FDA-approved specifically for weight management in adults and adolescents 12 and older with obesity (BMI of 30 or higher), or in adults with a BMI of 27 or higher who have at least one weight-related condition like high blood pressure. Wegovy’s maintenance dose goes well beyond Ozempic’s ceiling, reaching up to 7.2 mg per week.
How the Weight Loss Numbers Compare
In clinical trials for Ozempic (the SUSTAIN program, focused on diabetes patients), participants lost about 6.2% of their body weight on the 1 mg dose and 7.2% on the 2 mg dose over 40 weeks. For a 220-pound person, that works out to roughly 14 to 16 pounds.
Wegovy’s clinical trials (the STEP program) tested the higher 2.4 mg dose in people without diabetes and consistently showed weight loss in the range of 12% to 15% of body weight over about 68 weeks. For that same 220-pound person, that’s 26 to 33 pounds. The newer, even higher doses now available with Wegovy push results further still. The gap between the two medications isn’t subtle. Wegovy roughly doubles the weight loss you’d see with Ozempic, largely because the higher dose suppresses appetite more aggressively.
Why Some People Use Ozempic for Weight Loss Anyway
Despite Wegovy being the purpose-built weight loss version, many people end up on Ozempic instead. The most common reason has been availability. Wegovy faced persistent shortages for years after its launch, and Ozempic was easier to get. Some doctors also prescribe Ozempic off-label for weight loss in patients who have type 2 diabetes and want both blood sugar control and weight reduction in a single prescription.
Insurance plays a role too. Many insurance plans cover Ozempic for diabetes but won’t cover Wegovy for weight loss. If you have type 2 diabetes and qualify for Ozempic through your insurer, you may end up on it by default, even if your primary goal is losing weight.
Cost Differences
As of late 2025, Novo Nordisk sells both injectable Wegovy and Ozempic at $349 per month for consumers purchasing directly from the manufacturer, telehealth partners, or retail pharmacies. The one exception is the 2 mg dose of Ozempic, which remains at $499 per month. New customers can get the lower starter doses of either drug (0.25 mg and 0.5 mg) for $199 for the first two months. Oral versions of these drugs, once available, are expected to cost $149 per month.
Without insurance, the out-of-pocket cost is essentially the same for both. The real financial difference comes down to what your plan covers. A plan that covers diabetes medications but excludes weight management drugs could make Ozempic far cheaper for you personally, even though the list prices are similar.
Side Effects at Higher Doses
More semaglutide means more stomach-related side effects. In Wegovy’s clinical trials, 73% of people on the drug reported gastrointestinal issues, compared to 47% on placebo. The most common were nausea (44%), diarrhea (30%), and vomiting (25%). Severe GI reactions occurred in about 4% of Wegovy users versus under 1% of placebo users. These side effects tend to peak during the dose escalation period, when your body is adjusting to each new increase.
Both medications use a gradual dose-escalation schedule, starting at 0.25 mg and stepping up every four weeks, specifically to minimize nausea and vomiting. Ozempic’s escalation stops much sooner since the target dose is lower. Wegovy’s escalation takes longer and pushes through to higher doses, which means more weeks of adjustment and a greater chance of side effects along the way. Most people find the nausea manageable and temporary, but some need to slow the escalation or stay at a lower dose.
Practical Differences in How You Use Them
Both are injected once a week under the skin, typically in the stomach, thigh, or upper arm. Wegovy comes as a single-use pen: you inject it once and throw it away. Ozempic uses a multi-use pen that holds multiple doses, and you attach a new needle each time. Neither difference is a dealbreaker, but the single-use design is slightly simpler if you’re new to self-injections.
The escalation timeline also differs in practice. With Ozempic, you may reach your maintenance dose within 8 to 12 weeks. With Wegovy, reaching the highest available dose takes considerably longer because there are more steps and each step lasts at least four weeks.
Which One Is Right for Your Goal
If your primary goal is weight loss and you don’t have type 2 diabetes, Wegovy is the better tool. It’s FDA-approved for that purpose, reaches higher doses, and produces roughly twice the weight loss seen with Ozempic in clinical trials. It also carries FDA-approved indications for reducing cardiovascular risk in people with obesity and for treating a form of fatty liver disease with moderate to advanced scarring.
If you have type 2 diabetes, the decision is more nuanced. Ozempic handles blood sugar control effectively, and you’ll lose some weight in the process. Your doctor may start you on Ozempic for diabetes and consider switching to or adding Wegovy if weight loss is a priority. In some cases, insurance will cover Ozempic but not Wegovy, which makes the choice for you regardless of what the clinical data says. The bottom line: same molecule, but dose matters enormously. More semaglutide equals more weight loss, more side effects, and a longer ramp-up period. Wegovy delivers all three.